| Name | Title | Contact Details |
|---|
SMART CHEMISTRY WITH CHARACTER. The CHT Group is a medium-sized global player for sustainable specialty chemicals. After the foundation of CHT R. Beitlich GmbH in 1953 in Tübingen, the company has developed to a worldwide operating group with focus on innovative chemicals as function generators, auxiliaries and additives for industrial processes. The products optimise production processes in many industries and have an influence on the functionality, appearance and quality of the end-products on the consumer market. Then as now, the head office and the centres of competence of the business fields are located at the headquarters of the company CHT Germany GmbH in Tübingen (Ger). The range of dyes is developed, produced and commercialised by the Swiss subsidiary company CHT Switzerland AG (former BEZEMA AG) in Montlingen. With worldwide approx. 2,500 staff members in 28 companies and additional sales agencies the company group provides its products and services in more than 120 countries – on all continents. In strategy and organisation the group is focused on a value-oriented and sustainable corporate policy. Four business fields have the operative responsibility for the CHT business development: Textile, Textile Care, Construction Chemistry and General Industries. Production and finishing of textiles: Process auxiliaries, function generators and additives for pretreatment, dyeing, textile printing, flock, finishing, coating, jeans & garment, fiber production and textiles dyes. Washing Solutions: Detergents and auxiliaries for industrial laundries and for the feather and down industry. Construction: Additives, binders and special components for mineral systems and paints & coatings. General Industries: Silicones for Material Solutions, Consumer Care Solutions, Paper Solutions, Agricultural Solutions, Leather Solutions and Mining Solutions. In addition the CHT Group successfully established itself in PET recycling.
Kuveyt Türk Katılım Bankası 31 Mart 1989dan bu yana faizsiz finans alanında faaliyetlerini yürütmektedir. Kuveyt Türk, müşteri odaklı yaklaşımı, teknoloji-inovasyon çalışmaları ve dijital dönüşüm adımlarıyla sektöründeki öncü konumunu devam ettirmektedir. COĞRAFİ KAPSAMA Türkiyede 400ün üzerinde şubesi olan Kuveyt Türkün, yurt dışında Bahreyn şubesi ve %100 iştiraki olan KT Bank AGnin Almanyada 4 şubesi bulunmaktadır. ÖNCÜ ve LİDER BANKA Kuveyt Türk, aktif büyüklükte ve altın bankacılığında katılım bankaları arasında ilk sıradadır. 2010da Avrupanın ve Türkiyenin ilk banka kira sertifikası (sukuk) işlemini gerçekleştirmiş ve 2018de Türkiyenin en yüksek tutarlı sukuk ihraç hacmine ulaşmıştır. 2010da bir ilke daha imza atarak Türkiyede bankacılık sektörünün ilk Ar-Ge merkezini kurmuştur. Günümüzde iki Ar-Ge merkezine sahip tek bankadır. MEGA PROJELERE DESTEK Kuveyt Türk, Çanakkale 1915 Köprü Projesine 200 milyon Euro, Niğde-Ankara Otoyol Projesine ise 100 milyon Euro ile katılım sağlamış ve yenilenebilir enerji alanındaki toplam fonlamayı 740 milyon dolara çıkartmıştır. LONCA GİRİŞİMCİLİK MERKEZİ Kuveyt Türk, genç girişimcilere destek olmak amacıyla 2017de kurduğu Lonca Girişimcilik Merkezi ile her yıl 3 farklı dönemde toplamda 30 girişimi desteklemektedir. DEĞERLERİMİZLE BÜYÜYORUZ Toplumsal değerleri temel alarak ve kültürel varlıklara sahip çıkarak önemli sosyal sorumluluk projelerine imza atan Kuveyt Türk, "Değerlerimizle büyüyoruz" stratejisi doğrultusunda birçok restorasyon projesi üstlenmekte, Türk-İslam sanatlarına destek vermekte, kitap ve belgesel gibi kalıcı eserleri ise gelecek nesillere ulaştırmaktadır. GÜÇLÜ SERMAYE Kuveyt Türkün hisselerinin %57,81i Kuwait Finance Housea (KFH), %24,49u Türkiye Cumhuriyeti Vakıflar Genel Müdürlüğüne, %8,36sı Wafra Uluslararası Yatırım Kuruluşuna, %8,36sı İslâm Kalkınma Bankasına, %0,98lik kısmı ise gerçek ve tüzel kişilere aittir. Bankanın öz varlıkları 82 milyar TLnin üzerindedir.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Sycamore is a specialty wholesale broker, focusing on hospitality, cannabis, energy and niche personal lines dwellings. Sycamore Specialty Underwriters started its wholesale broker operations in 2014. Partnering with insurance companies around the country, Sycamores goal is to make sure agents seeking specialized products have a one stop-shop to finding coverage for their clients.